Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Yang, LZ; Kockskämper, J; Heinzel, FR; Hauber, M; Walther, S; Spiess, J; Pieske, B.
Urocortin II enhances contractility in rabbit ventricular myocytes via CRF(2) receptor-mediated stimulation of protein kinase A.
Cardiovasc Res. 2006; 69(2):402-411
Doi: 10.1016/j.cardiores.2005.10.015
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-authors Med Uni Graz
- Heinzel Frank
- Kockskämper Jens
- Pieske Burkert Mathias
- Walther Stefanie
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Objective: Urocortin II (UcnII), a peptide of the corticotropin-releasing factor (CRF) family, exerts profound actions on the cardiovascular system. Direct effects of UcnII on adult cardiomyocytes have not been evaluated before. Our aim was to characterize functional effects of UcnII on cardiomyocytes and to elucidate the underlying signaling pathway(s) and cellular mechanisms. Methods: Rabbit ventricular cardiomyocytes were stimulated at 0.5 Hz (22-25 degrees C). Unloaded cell shortening (FS, edge detection), [Ca2+](i) transients (Fluo-4), and L-type Ca2+ currents (I-Ca, whole-cell patch clamping) were measured. Sarcoplasmic reticulum (SR) Ca2+ load was assessed by rapid application of caffeine (20 mmol/L). Results: UcnII increased cell shortening and accelerated relaxation in a time- and concentration-dependent manner (EC50: 10.7 nmol/L). The inotropic effect of UcnII was maximal at 100 nmol/L (35% +/- 11% increase in FS, n=8, P<0.05). The inotropic and lusitropic actions of UcnII were largely eliminated by inhibition of CRF2 receptors (10 nmol/L antisauvagine-30, n = 5) or protein kinase A (PKA, 500 nmol/L H-89, n=5). UcnII increased [Ca2+](i) transient amplitude (by 63% +/- 35%, n=7, P<0.05) and decreased the time constant for decay (from 800 +/- 63 to 218 +/- 27 ms, n=7,P<0.001). UcnII also increased SR Ca2+ load (by 19% +/- 7%, n=7,P<0.05) and fractional Ca2+ release (from 57% +/- 7% to 98% +/- 2%, n=7, P<0.01). I-Ca was augmented by 32.7% +/- 10.0% (n=9, P<0.05) and the I-Ca-V relationship was shifted by - 15 mV during UcnII treatment. Conclusion: UcnII exerts positive inotropic and lusitropic effects in cardiomyocytes via CRF2 receptor-mediated stimulation of PKA which augments I-Ca and SR Ca2+ load to increase SR Ca2+ release and [Ca2+](i) transients. (C) 2005 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
- Find related publications in this database (using NLM MeSH Indexing)
- Animals -
- Corticotropin-Releasing Hormone - pharmacology
- Cyclic AMP-Dependent Protein Kinases - metabolism
- Enzyme Activation -
- Heart Ventricles -
- Microscopy, Confocal -
- Myocardial Contraction - drug effects
- Myocytes, Cardiac - drug effects Myocytes, Cardiac - metabolism
- Patch-Clamp Techniques -
- Peptide Fragments - pharmacology
- Rabbits -
- Receptors, Corticotropin-Releasing Hormone - metabolism
- Stimulation, Chemical -
- Urocortins -
- Find related publications in this database (Keywords)
- peptide hormones
- myocytes
- e-c coupling
- protein kinase A
- SR (function)